Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1875 to 1924 of 6456 in total 
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
938\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
sorcin (22 kda protein) (cp-22) (v19). [source:swissprot;acc:p30626]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.442\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.087\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.355\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor 3 subunit 1 (spliceosome associated protein 114) (sap 114) (sf3a120). [source:swissprot;acc:q15459]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.246\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.618\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03588\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
939\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
breast cancer type 1 susceptibility protein. [source:swissprot;acc:p38398]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
216.501\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.27\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
brg1-binding protein eld/osa1; eld (eyelid)/osa protein. [source:refseq;acc:nm\_020732]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.085\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.355\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
940\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
calcium-dependent protease, small subunit (calpain regulatory subunit) (calcium-activated neutral proteinase) (canp). [source:swissprot;acc:p04632]\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.442\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
205.088\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03586\vspace{3pt}}\\\cline{3-3}\cline{6-6}
&&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
7.354\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
941\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
swi/snf-related, matrix-associated, actin-dependent regulator of chromatin subfamily f member 1 (swi-snf complex protein p270) (b120). [source:swissprot;acc:o14497]\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.437\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
205.083\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03586\vspace{3pt}}\\\cline{3-3}\cline{6-6}
&&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
7.354\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
942\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
grancalcin. [source:swissprot;acc:p28676]\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.442\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
205.088\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03586\vspace{3pt}}\\\cline{3-3}\cline{6-6}
&&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
7.354\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
943\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
programmed cell death protein 6 (probable calcium-binding protein alg- 2). [source:swissprot;acc:o75340]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
212.437\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.083\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sorcin (22 kda protein) (cp-22) (v19). [source:swissprot;acc:p30626]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.442\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.087\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03586\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
944\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
arg/abl-interacting protein 2 isoform 2; arg binding protein 2. [source:refseq;acc:nm\_021069]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.191\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.319\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
programmed cell death protein 6 (probable calcium-binding protein alg- 2). [source:swissprot;acc:o75340]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.437\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.083\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03586\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
945\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
brg1-binding protein eld/osa1; eld (eyelid)/osa protein. [source:refseq;acc:nm\_020732]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
212.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.085\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dihydropyrimidine dehydrogenase [nadp+] precursor (ec 1.3.1.2) (dpd) (dhpdhase) (dihydrouracil dehydrogenase) (dihydrothymine dehydrogenase). [source:swissprot;acc:q12882]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
229.116\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.823\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.293\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
946\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynein intermediate chain 2, cytosolic (dh ic-2) (cytoplasmic dynein intermediate chain 2). [source:swissprot;acc:q13409]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
225.557\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.271\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.286\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
histone h4. [source:swissprot;acc:p02304]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.765\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.902\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03576\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
947\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
arg/abl-interacting protein 2 isoform 2; arg binding protein 2. [source:refseq;acc:nm\_021069]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
212.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.191\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03567\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
stem cell growth factor; lymphocyte secreted c-type lectin; lymphocyte secreted c-type lectin. [source:refseq;acc:nm\_002975]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
177.776\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170.499\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.277\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
948\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 4 (spry-4). [source:swissprot;acc:q9c004]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
225.167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.922\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.245\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
target of myb protein 1. [source:swissprot;acc:o60784]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.254\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.824\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03541\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
949\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
huntingtin-associated protein-interacting protein (duo protein). [source:swissprot;acc:o60229]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
217.253\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.826\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0354\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 3 (spry-3). [source:swissprot;acc:o43610]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.922\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.245\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
950\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-repair protein complementing xp-g cells (xeroderma pigmentosum group g complementing protein) (dna excision repair protein ercc-5). [source:swissprot;acc:p28715]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
252.873\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
261.821\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03539\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 1 (spry-1) (fragment). [source:swissprot;acc:o43609]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
225.167\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
217.922\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
7.245\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
951\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 2 (spry-2). [source:swissprot;acc:o43597]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
triple functional domain protein (ptprf interacting protein). [source:swissprot;acc:o75962]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.253\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.827\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03539\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
952\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynein intermediate chain 1, cytosolic (dh ic-1) (cytoplasmic dynein intermediate chain 1). [source:swissprot;acc:o14576]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.448\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.232\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.216\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
target of myb1-like 2; target of myb1 (chicken) homolog-like 2. [source:refseq;acc:nm\_144678]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.252\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.83\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03537\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
953\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
c-type lectin superfamily member 1 precursor (cartilage-derived c-type lectin). [source:swissprot;acc:o75596]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
178.033\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.213\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
polymyositis/scleroderma autoantigen 2 (autoantigen pm/scl 2) (polymyositis/scleroderma autoantigen 100 kda) (pm/scl-100) (p100 polymyositis-scleroderma overlap syndrome associated autoantigen). [source:swissprot;acc:q01780]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
198.494\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.466\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03512\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
954\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
maleylacetoacetate isomerase (ec 5.2.1.2) (maai) (glutathione s- transferase zeta 1) (ec 2.5.1.18) (gstz1-1). [source:swissprot;acc:o43708]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
267.447\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
276.773\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03487\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
thioredoxin-like; pkc-interacting cousin of thioredoxin. [source:refseq;acc:nm\_006541]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.412\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.609\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.197\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
955\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bai1-associated protein 1; ww domain-containing protein 3; atrophin-1 interacting protein 3. [source:refseq;acc:nm\_004742]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
221.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.906\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.176\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial 60s ribosomal protein l27 (l27mt) (hspc250). [source:swissprot;acc:q9p0m9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.163\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
239.205\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03479\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
956\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex protein 1, alpha subunit (tcp-1-alpha) (cct-alpha). [source:swissprot;acc:p17987]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
135.379\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
128.225\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.154\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vinexin (sh3-containing adaptor molecule-1) (scam-1). [source:swissprot;acc:o60504]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.812\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.732\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03458\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
957\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
a-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (a-raf-1) (proto-oncogene pks). [source:swissprot;acc:p10398]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
129.913\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
134.399\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03453\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator-like 1 (ralgds-like 1). [source:swissprot;acc:q9nzl6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
168.592\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
161.452\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.14\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
958\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (raf-1) (c-raf). [source:swissprot;acc:p04049]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
129.921\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
134.406\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03452\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine protease htra2, mitochondrial precursor (ec 3.4.21.-) (high temperature requirement protein a2) (htra2) (omi stress-regulated endoprotease) (serine proteinase omi). [source:swissprot;acc:o43464]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.459\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.338\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.121\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
959\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit-like protein 12.3 (p205) (receptor of activated protein kinase c 1) (rack1) (receptor for activated c kinase). [source:swissprot;acc:p25388]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
237.558\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
229.677\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03431\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
probable serine protease htra4 precursor (ec 3.4.21.-). [source:swissprot;acc:p83105]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.461\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.343\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.118\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
960\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable serine protease htra3 precursor (ec 3.4.21.-). [source:swissprot;acc:p83110]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
218.462\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.345\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.117\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zuotin related factor-1 (m-phase phosphoprotein 11). [source:swissprot;acc:q99543]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
237.558\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
229.677\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03431\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
961\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine protease htra1 precursor (ec 3.4.21.-) (l56). [source:swissprot;acc:q92743]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.468\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.357\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.111\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 56 kda regulatory subunit, epsilon isoform (pp2a, b subunit, b' epsilon isoform) (pp2a, b subunit, b56 epsilon isoform) (pp2a, b subunit, pr61 epsilon isoform) (pp2a, b subunit, r5 epsilon isoform). [source:swissprot;acc:q16537]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
130.066\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
134.527\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0343\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
962\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin g2. [source:swissprot;acc:q16589]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitotic spindle assembly checkpoint protein mad2b (mad2-like 2) (hrev7). [source:swissprot;acc:q9ui95]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.656\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.547\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7.109\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/